Figures
Abstract
The phosphopantetheinyl transferases (PPTases) are responsible for the activation of the carrier protein domains of the polyketide synthases (PKS), non ribosomal peptide synthases (NRPS) and fatty acid synthases (FAS). The analysis of the Streptomyces ambofaciens ATCC23877 genome has revealed the presence of four putative PPTase encoding genes. One of these genes appears to be essential and is likely involved in fatty acid biosynthesis. Two other PPTase genes, samT0172 (alpN) and samL0372, are located within a type II PKS gene cluster responsible for the kinamycin production and an hybrid NRPS-PKS cluster involved in antimycin production, respectively, and their products were shown to be specifically involved in the biosynthesis of these secondary metabolites. Surprisingly, the fourth PPTase gene, which is not located within a secondary metabolite gene cluster, appears to play a pleiotropic role. Its product is likely involved in the activation of the acyl- and peptidyl-carrier protein domains within all the other PKS and NRPS complexes encoded by S. ambofaciens. Indeed, the deletion of this gene affects the production of the spiramycin and stambomycin macrolide antibiotics and of the grey spore pigment, all three being PKS-derived metabolites, as well as the production of the nonribosomally produced compounds, the hydroxamate siderophore coelichelin and the pyrrolamide antibiotic congocidine. In addition, this PPTase seems to act in concert with the product of samL0372 to activate the ACP and/or PCP domains of the antimycin biosynthesis cluster which is also responsible for the production of volatile lactones.
Citation: Bunet R, Riclea R, Laureti L, Hôtel L, Paris C, Girardet J-M, et al. (2014) A Single Sfp-Type Phosphopantetheinyl Transferase Plays a Major Role in the Biosynthesis of PKS and NRPS Derived Metabolites in Streptomyces ambofaciens ATCC23877. PLoS ONE 9(1): e87607. https://doi.org/10.1371/journal.pone.0087607
Editor: Paul Hoskisson, University of Strathclyde, United Kingdom
Received: October 29, 2013; Accepted: December 20, 2013; Published: January 31, 2014
Copyright: © 2014 Bunet et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the French National Research Agency through the Laboratory of Excellence ARBRE (ANR-12- LABXARBRE-01), the Région Lorraine and by the Deutsche Forschungsgemeinschaft (DFG) with an Emmy Noether fellowship (DI1536/1–3) and a Heisenberg fellowship (DI1536/4-1) to JSD, and with a DFG grant “Biologische Chemie der Antimycine und Blastmycinone in Streptomyces ambofaciens” (DI1536/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Phosphospantetheinylation is absolutely required for the biosynthesis of fatty acids, polyketides and nonribosomally synthesized peptides [1]. This reaction, catalyzed by the Mg2+-dependent phosphopantetheinyl transferases (PPTases), allows the activation by posttranslational modification of the acyl carrier protein (ACP) domains in the fatty acid synthases (FASs) and polyketide synthases (PKSs) and of the peptidyl carrier protein (PCP) domains in the nonribosomal peptide synthases (NRPSs). This activation, which is essential for the function of the carrier protein domains, occurs by the transfer of the 4′-phosphopantetheine (P-pant) moiety of coenzyme A to a conserved serine residue within the active site of the protein substrates. The free thiol of the P-pant residue then permits attachment of the building blocks and the growing acyl or polypeptide chains to the carrier proteins as thioesters.
PPTases are divided into three groups based upon their sequence homologies and substrate spectra [2]. The members of the first group are usually associated with primary metabolism and catalyze the activation of the fatty acid ACPs. They have been classified as ACPS-type in reference to the ACPS (for holo-acyl carrier protein synthase) protein of Escherichia coli, the first P-pant transferase to be cloned and characterized [3]. PPTases of this group are usually about 120 aa in length and act as homotrimers. They have been shown to accept ACPs from type II PKSs as substrate in vitro [4] and probably in vivo [5]. The prototype of the second group of PPTases, Sfp, activates the PCP domains of the surfactin synthetase in Bacillus subtilis [6]. The Sfp-type PPTases are often approximately twice the size of the ACPS-type and they are monomeric in structure, but are considered as pseudo-dimeric because they are composed of two sub-domains resembling two ACPS monomers [7]. This group of enzymes exhibits broad spectrum activity. They can indeed modify PCP domains of NRPSs as well as ACP domains of PKSs and FASs. Nevertheless, the Sppt P-pant transferase of the cyanobacterium Synechocystis sp. PCC6803 is only able to activate its cognate fatty acid synthesis carrier protein [8]. Two distinct sub-families can be distinguished in the Sfp-type PPTases based on conserved amino-acid motifs [9], [10]: the F/KES family, which includes the majority of PPTases associated with NRPS and siderophore synthesis, and the W/KEA family which includes Sfp from B. subtilis and PPTases involved in polyketide biosynthesis as well as the enzymes in glycolipid or lysine biosynthesis. In bacteria, this type of PPTase genes has been found both in NRPS and PKS gene clusters [11], [12] but also independent of secondary metabolite gene clusters [13]. The third group of PPTases was identified in yeasts. They correspond to a domain of about 140 amino acids located in the C-terminal part of type I FAS that activates the ACP domain in cis by self-phosphopantetheinylation [14]. Such integrated PPTase domains were also identified in plants and within bacterial PKSs [9].
The bacteria belonging to the genus Streptomyces are well known for their ability to produce a wide range of natural products. Genome sequence analysis has revealed the presence of usually more than 20, sometimes 30, secondary metabolite gene clusters in these bacteria including numerous polyketides and non ribosomal peptides, many of which being used in human medicine. The genome of each Streptomyces species usually contains several PPTase genes, but their number does not correspond to the multiple P-pant requiring metabolic pathways. Indeed the number of ACP and PCP containing loci largely exceeds the number of PPTase genes as revealed by analysis of sequenced genomes. In the Streptomyces model, Streptomyces coelicolor A3(2), only three PPTases are present for 22 secondary metabolite gene clusters including two type II and type I PKS gene clusters, four NRPS gene clusters and the prodiginine producing red cluster which also encodes PCPs and ACPs [15], [16]. In Streptomyces griseus, the genome analysis has revealed two PPTases for no less than 16 clusters encoding PKS and/or NRPS [17], and in Streptomyces avermitilis, seven PPTase genes including a possible pseudogene and a domain within a type I PKS gene are present for 13 PKS and 8 NRPS gene clusters [18], [19]. This reflects the flexibility of the P-pant transferase proteins. However, a limited number of PPTase in vivo studies has been published for Streptomyces and to our knowledge none of them has studied in detail the set of the biosynthetic pathways under the dependency of a single PPTase. The reason is likely that most of the genomes have been just recently sequenced and that many metabolites produced by uncharacterized clusters are still unknown. The role of the three PPTase genes in S. coelicolor A3(2) was recently studied [5]. Among them, only redU (sco5883) is located within a secondary metabolite gene cluster, the red cluster responsible for the prodigiosin biosynthesis. RedU is only involved in prodigiosin production by activating the RedO PCP [5], [20]. The two other genes, sco4744 and sco6673, encode an ACPS-type and an Sfp-type PPTase of the F/KES family. SCO4744 is likely responsible for the fatty acid biosynthesis: it is the only ACPS-type protein and no mutant for sco4744 could be isolated as expected for an essential gene. But it is considered as a ‘promiscuous’ PPTase because the double mutant redU-sco6673 was still able to synthesize actinorhodin (ACT) and the grey spore pigment, compounds produced by type II PKS gene clusters, and it has also been proposed to activate the ACP domains encoded within the red cluster [5]. On the other hand, the product of sco6673 was shown to be required for the production of the non ribosomal lipopeptide, the calcium dependent antibiotic (CDA). It has been suggested that the SCO6673 PPTase could also participate in the synthesis of other non ribosomal peptides such as the siderophore coelichelin [5]. Thus, from this study, it is tempting to speculate that the PPTases SCO4744 and SCO6673 are involved in the activation of all ACPs and PCPs (with the exception of RedO) encoded within the S. coelicolor genome but their respective roles remain to be determined.
Before the genome sequence and despite decades of studies, Streptomyces ambofaciens ATCC23877 was only known to produce the cytotoxic pyrrolamide congocidine and the macrolide spiramycin, which is used in human medicine as antibacterial drug and for the treatment of toxoplasmosis. Mining of the S. ambofaciens ATCC23877 genome sequence has unveiled the presence of 25 secondary metabolite gene clusters [21]. The sequencing data also resulted in the full characterization of the spiramycin cluster, a type I PKS gene cluster [22] and the identification of the congocidine cluster, a NRPS gene cluster [23]. The analysis of cryptic clusters resulted in the discovery of several secondary metabolites produced by S. ambofaciens ATCC23877: the novel bioactive 51-membered macrolide stambomycins [24], the kinamycins [25], [26], the siderophores desferrioxamines E and B and coelichelin [27], the antifungal antimycins [28] and the antimycin-derived blastimycinones and related butenolides [29]. In fact, although S. ambofaciens ATCC23877 and S. coelicolor A3(2) are very close relatives [30], they share only 11 secondary metabolite genes or gene clusters (unpublished data), e.g. those coding for the desferrioxamine, coelichelin, geosmin and the grey spore pigment.
The S. ambofaciens ATCC23877 genome encodes four PPTase genes, two of them corresponding to the orthologues of sco4744 and sco6673 that will be designated acpS-like and sco6673-like, respectively. The two other genes are located within secondary metabolite gene clusters, alpN (samT0172) in the kinamycin type II PKS gene cluster [25] and samL0372 in the antimycin hybrid NRPS-PKS gene cluster. No PPTase genes have been identified in the seven other clusters encoding PCP and/or ACP proteins/domains: a type II PKS cluster responsible for the spore pigmentation, three type I PKS clusters including the spiramycin and stambomycin loci, and three NRPS clusters including those responsible for the congocidine and coelichelin biosynthesis.
During the course of this work, the role of these P-pant transferases has been investigated, showing that the F/KES family member SCO66733-like has an unexpected large pleiotropic role in contrast to its orthologue in S. coelicolor A3(2).
Materials and Methods
Bacterial Strains, Plasmids and Growth Conditions
Bacterial strains, plasmids, BACs and cosmids used in this study are listed in Table 1. Streptomyces strains were manipulated as described previously [25], [31]. Morphological differentiation, in particular the ability to sporulate, was assessed on SFM medium [31]. Production of antibiotics was assessed on/in R2 (kinamycin and stambomycin) and on/in HT [31] or MP5 [32] (spiramycin, stambomycin and congocidine). Antimycin production was determined in SFM and the related volatile production, blastmycinones and butenolides, on SFM. Siderophore biosynthesis was assessed on R2YE agar plates [31]. E. coli strains were cultivated in LB liquid medium [33]. For λ red genes induction, 10 mM of filtered L-arabinose was added to the culture. E. coli, Bacillus subtilis ATCC6633 and Micrococcus luteus were used as indicator strains in the bioassays.
DNA Manipulation
Isolation, cloning, and manipulation of DNA were carried out as previously described in [31] for Streptomyces and in [33] for E. coli. Pulsed-field gel electrophoresis (PFGE) analyses were performed as previously described [34]. Amplification of DNA fragments by PCR was performed with Taq DNA polymerase (NEB) or Takara polymerase (Fermentas), according to the manufacturer’s instructions. When needed, PCR products and restriction fragments were purified from agarose gels with the High Pure PCR product purification kit (Roche).
Construction of the S. ambofaciens Mutant Strains
The REDIRECT system [35] was used to make the in-frame deletion or gene replacement of the S. ambofaciens ATCC23877 PPTase encoding genes, as described [25], [36]. The aadA-oriT and aac(3)-IV-oriT mutagenesis cassettes used for gene replacement were synthesized by PCR using pIJ778 [35] and pSPM88T (Annabelle Thibessard, pers. com.) [37] as templates, respectively. E. coli BW251113/pKD20 [38] was first transformed with the BAC containing the PPTase gene of interest (samL0372, sco6673-like or sco4744-like), and then with the PCR product (aac(3)-IV-oriT mutagenesis cassette) to replace the targeted gene by homologous recombination. For the deletion of the two copies of alpN, E. coli BW251113/pIJ790 [35] was used instead of E. coli BW251113/pKD20 and was transformed with the F6 cosmid and then with the aadA-oriT cassette. The chloramphenicol resistance gene of the vector pBelo-BAC11 was replaced by a spectinomycin resistance gene, using the same strategy. E. coli ET12567/pUZ8002 was transformed with the mutated BACs or cosmid for conjugation with S. ambofaciens ATCC23877. Gene replacements were confirmed by PCR analysis using primer sets flanking the targeted genes and/or Southern blot analyses. PFGE analysis was also carried out for the alpN mutants to rule out the formation of large genomic rearrangements. To get in frame deleted mutants of alpN and of samL0372 and sco6673-like, the cassette was removed using respectively the Flip recombinase as described in [35] and the excisionase and integrase of pSAM2 as described in [37]. Only the start and stop codons of the genes remained after deletion. All primers used to generate the cassettes and to confirm the gene deletion are described in Table S1. For each gene, at least three independent mutants were isolated and analyzed for the secondary metabolite production with the exception of alpN for which two independent mutants were studied.
Complementation of the PPTase Mutants
To complement the ΔΔalpN mutants, a strategy similar to the one already used for other alp genes was used [39]. Briefly, the alpN gene including its putative promoter was amplified from the F6 cosmid with the primer set alpN-fwd/alpN-prom using high-fidelity Phusion polymerase (Finnzyme). After a standard A-tailing step, the 1,158-bp PCR product was cloned into pGEMT-easy (Promega) and the integrity of the insert was confirmed by sequencing. After restriction by EcoRI, the insert was cloned into pSET152 previously digested with the same enzyme to give pSET-alpN which was introduced in S. ambofaciens ATCC23877 by conjugation from E. coli (the plasmid integrates into the Streptomyces chromosomal φC31 attachment site by site-specific recombination). For the complementation of the Δsco6673-like mutants, the strategy was slightly different since the 5′ end of the gene overlaps with the 3′ end of the upstream gene. Therefore, only the orf of sco6673-like was amplified from the S. ambofaciens ATCC23877 genomic DNA with the Phusion high-fidelity polymerase (Thermo Scientific). The PCR product was cloned into pJET1.2/blunt and the integrity of the insert was confirmed by sequencing. After restriction digestion with NdeI and XbaI, the insert was cloned into the conjugative and integrative pIB139 vector under the control of the ermEp* promoter modified to have a typical Streptomyces ribosome binding site [36] giving the pIB-sco6673-like plasmid. Empty vectors pSET152 and pIB139 were used as controls.
Bioassays
To detect the production of kinamycins, bioassays were carried out from a plug of S. ambofaciens clones grown on R2 agar as previously described [25] using B. subtilis ATCC6633 as indicator strain. The congocidine bioassays were carried out on HT solid medium as described in [23] using E. coli DH5α as indicator strain.
Reverse-phase HPLC, LC-MS and GC-MS Analyses
The production of spiramycins and congocidine was assessed from MP5 liquid grown cultures of S. ambofaciens. After 4 days cultivation at 30°C, supernatants were filtered through Phenex-RC membrane (0.45 µm; Phenomenex) and 100 µl were analyzed by RP-HPLC on an Alliance HPLC unit equipped with a photodiode array detector 996 (Waters, Milford, USA) and with a Lichrosphere RP18 column (150×2 mm, 5 µm particle size and 10 nm porosity; Merck). A linear gradient from 5% to 75% acetonitrile in water was applied in the presence of 0.1% of trifluoroacetic acid for 70 min with a flow rate of 0.25 ml/min at a temperature of 30°C. Absorption was monitored at 232 nm for spiramycins and congocidin and at 297 nm specifically for congocidine. Purified spiramycins and congocidine were used as standard. The presence of stambomycins was determined from the S. ambofaciens wt and mutant strains overexpressing samR0484 (this gene lies within the stambomycin cluster and encodes a pathway-specific regulator of the LAL family and its overexpression is required to trigger the transcription of the stambomycin biosynthetic genes; [24]). LC-MS analyses were carried out from methanol extracts of mycelia grown either in MP5 liquid medium at 30°C [24] or on cellophane membranes lifted on R2 agar plates (4 days at 30°C). In the latter case, LC-MS analyses were carried out on an LTQ (ThermoFisher Scientific) ion trap mass spectrometer (Text S1). For antimycin detection, the strains were cultivated in SFM liquid medium at 28°C for three days and then culture samples (2 ml) were withdrawn, lyophylized, resuspended in 1 ml methanol and analyzed by LC-MS [28]. The production of blastmycinones and butenolides was assessed from cultures of S. ambofaciens strains grown on SFM plates for three to five days at 28°C. The volatiles were collected by use of a closed loop stripping apparatus as previously described [40] and GC-MS analyses of headspace extracts were performed as in [29]. The production of the siderophore coelichelin and desferrioxamines B and E was assessed from a S. ambofaciens culture grown on R2YE agar as described elsewhere [41]. Briefly, after growth on cellophane lifted on agar plates during 4 days at 30°C, siderophores were extracted from spent agar with one volume of MilliQ water, and, after lyophylisation, resuspended in MilliQ water according to the measured fresh weight of the biomass. The extracted siderophores were then analyzed by LC-ESI-MS (ThermoFisher Scientific) as in [41] (see Text S1).
Results
An Essential Role for the acpS-like Gene
The acpS-like gene of S. ambofaciens ATCC23877 is located within a region that is highly synthenic with the S. coelicolor region containing sco4744. Its product (123 aa) is homologous to PPTases of the ACPS family (Figure S1) and it shares 91% identity (95% similarity) with SCO4744. Similarly to sco4744 [5], we could not obtain any mutant of this gene. Numerous attempts of gene replacement were unsuccessful and only clones with a single crossover were obtained. Therefore, the acpS-like gene is likely essential and may be involved in fatty acid biosynthesis as proposed for its orthologue in S. coelicolor A3(2). Nevertheless, contrary to SCO4744, the ACPS-like PPTase does not seem to be capable of in vivo activation of ACPs involved in polyketide synthesis (see below).
AlpN, a PPTase Dedicated to Kinamycin Biosynthesis
The samT0172 gene (also designated alpN) is present in two copies on the S. ambofaciens ATCC23877 chromosome since it is part of the duplicated type II PKS gene cluster responsible for the kinamycin production [25], [26]. Its product (269 aa) is a Sfp-type PPTase that belongs to the W/KEA subfamily. AlpN shares the highest similarity with SSDG_05480 (70% identity/79% similarity) and ORF56 (60%/68%) which are encoded by Streptomyces pristinaespiralis (NCBI Reference Sequence: ZP_06913971.1) and within a type I PKS gene cluster located on the linear plasmid pSLA2-L of Streptomyces rochei [42] (Fig. S2), respectively. It has no orthologue in S. coelicolor A3(2) and shows only a weak identity (31%) with RedU which is involved in the prodigiosin biosynthesis and is also member of the W/KEA subfamily.
Based on its location within the alp cluster, the alpN product may activate the unique ACP (AlpC) encoded within the alp cluster [25]. To confirm this hypothesis, the two copies of the alpN open reading frames were removed by in-frame deletion. The mutants, designated ΔΔalpN, showed growth and morphological differentiation identical to those of the wt strain under different growth conditions (data not shown). In particular, the grey color characteristic of mature spores was visible indicating that AlpN is not responsible for the activation of the carrier protein involved in the spore pigment biosynthesis. The alp cluster genes were previously shown to be associated with the production of kinamycin and a diffusible orange pigment on solid or in liquid R2 medium, the pigment being likely either a degradation or modification product of kinamycin [25], [26]. On R2 surface-grown cultures, no pigment could be detected in the ΔΔalpN mutant strain after an incubation time of up to seven days, while orange pigmentation was clearly visible after 24 hours of growth in the parental strain (Fig. 1A). Plugs from agar plates were then assessed for their ability to inhibit the growth of B. subtilis, which is sensitive to kinamycins (Fig. 1C). Only the S. ambofaciens wt strain was active against the indicator strain. The reintroduction of a copy of alpN under the control of its own promoter in the ΔΔalpN clones by using the plasmid pSETalpN restored both pigment and antibiotic production (Fig. 1B; Fig. 1C), thus confirming the direct link between the deletion of the two copies of alpN and the phenotypes observed in the mutants.
(A) Pigment synthesis was assessed on R2 plates in the wild-type (WT) strain and alpN double deletion mutants (two independent clones ΔΔalpN2-1 and ΔΔalpN4-1 are shown) and (B) in the ΔΔalpN2-1 mutant carrying the pSET152 derivative pSETalpN in comparison with the WT/pSET152 and ΔΔalpN2-1/pSET152 control strains. The photos were taken from below the plate. (C) Kinamycin production was visualized by the inhibition of B. subtilis growth. Streptomyces strains were grown on R2 agar, and a plug of mycelia was placed on an LB plate seeded with B. subtilis.
Since the type I PKS gene clusters responsible for the production of the spiramycin and stambomycin macrolides do not contain a PPTase gene, we next checked if the deletion of alpN impaired the biosynthesis of these compounds. HPLC analysis of the culture supernatant of the ΔΔalpN clone grown in MP5, a suitable medium for the macrolide production, showed that the deletion of this gene did not affect spiramycin production (Fig. S3). The effect on stambomycin biosynthesis was determined with the ΔΔalpN clone overexpressing samR0484 (ΔΔalpN/OE484; see Materials and Methods). Analysis of the mycelium extract of ΔΔalpN/OE484 by LC-MS also revealed that the biosynthesis of stambomycins is not impaired in the mutant (Fig. S4).
In a similar way, blastmycinones and butenolides, the volatiles that are degradation products of the antimycins, were detected in the ΔΔalpN mutant (Fig. S5). Altogether, these data strongly suggest that AlpN is only required for the activation of the AlpC ACP involved in the biosynthesis of the aromatic polyketide kinamycin.
SAML0372, an Unusual PPTase
The hybrid NRPS-PKS gene cluster responsible for the biosynthesis of antimycins and of the related volatile compounds blastmycinones and butenolides [28], [29], is the other cluster encoding a PPTase (SAML0372). Surprisingly, while the three characterized antimycin clusters are well conserved (those identified in Streptomyces albus J1074, Streptomyces S4 and S. ambofaciens ATCC23877 [43]), samL0372 as well as the downstream small orf samL0373 of unknown function are present only in S. ambofaciens in the middle of the cluster. In addition, SAML0372 is a protein of 337 aa that contains a long spacer (147 aa) which is absent in all other PPTases characterized so far (Fig. 2). We nevertheless considered SAML0372 as a potential PPTase because it contains the three amino acid motifs characteristic of a PPTase, and also the residues participating in substrate binding and catalysis are present in the protein (Fig. 2). Although SAML0372 contains a FxxKEA domain, it was assigned to the F/KES subfamily since it possesses in addition to the three motifs conserved within PPTases the motif 1a specific to this subfamily [9].
The aa residues conserved in at least 7/9 proteins are shaded in black. SAML0372 belongs to the F/KES subfamily and the motifs characteristic of this subfamily [9] are red boxed. YP_006242413: Streptomyces hygroscopicus subsp. jinggangensis 5008; ZP_07314903: Streptomyces griseoflavus Tü4000; ZP_01064840: Vibrio sp. MED222; BAM21050: Streptomyces blastmyceticus; ZP_11171572: Alcanivorax hongdengensis A-11-3; ZP_10439114: Pseudomonas extremaustralis 14-3 substr. 14-3b; ZP_07090824: Corynebacterium genitalium ATCC 33030; ZP_05043693: Alcanivorax sp. DG881.
To determine the role of this atypical PPTase, independent mutants deleted for samL0372 were isolated. Like the ΔΔalpN strains, the samL0372 mutants were not affected in growth and morphological differentiation including grey spore pigment production (data not shown). The production of antimycins and its degradation products, the volatile blastmycinones and butenolides, were surveyed by LC-MS and by use of a closed-loop stripping apparatus (CLSA) in combination with GC-MS, respectively. The mutant strains did not produce the antimycins A1 to A4 that are present in the extract of the wt strain (Fig. 3). Accordingly, GC-MS analysis confirmed the absence of blastmycinones and butenolides in the volatile fraction emitted by the agar plate culture of the mutants, while these compounds were produced in large amounts by the parental strain under the same growth conditions (Fig. S5). The dilactone scaffold of the antimycins is generated by a hybrid NRPS-PKS assembly line which involves a PCP protein, two PCP domains within the dimodule NRPS and an ACP domain within the PKS [44]. Therefore, our results strongly suggest that SAML0372 activates either the acyl- or peptidyl carrier domains or both involved in the antimycin production. Nevertheless, the analysis of the sco6673-like mutant (see below) indicates that SAML0372 probably acts only on one type of domain (ACP or PCP), but not on both.
(A) LC-MS ion chromatograms (m/z = 571, [M+Na]+) of a) antimycin A1 and of methanolic culture extract of the S. ambofaciens ATCC23877 b) wild-type, c) Δsco6673-like, d) Δsco6673-like/pIBsco6673-like and e) ΔsamL0372 stains grown in liquid SFM. (B) LC-MS ion chromatograms (m/z = 557, [M+Na]+) of a) antimycin A2 and of methanolic culture extract of the S. ambofaciens ATCC23877 b) wild-type, c) Δsco6673-like, d) Δsco6673-like/pIBsco6673-like and e) ΔsamL0372 strains grown in liquid SFM. The peaks marked by an asterisk represent an unidentified compound that is not from the antimycin family.
Based on its location within the antimycin cluster, we suspected that the role of the samL0372 gene product was specifically dedicated to the production of the antimycins and of the related volatiles. Indeed, when grown on R2 agar plates, the mutant strains still produced the orange pigment and showed antibacterial activity against B. subtilis likely due to the kinamycin production (Fig. S6). In addition, on HT or MP5 agar plates, the mutant strains exhibited antibacterial activity against E. coli indicating that the mutant was still able to produce congocidine (the other known antimicrobial compounds produced by S. ambofaciens ATCC23877 are not active against E. coli), as confirmed by HPLC analysis of liquid culture extracts (Fig. S6). Finally, HPLC analysis of MP5 liquid culture extracts confirmed that the production of spiramycin was not impaired in the mutant strain (Fig. S6). Therefore, the role of SAML0372 is likely limited to the antimycin biosynthetic pathway.
A Pleiotropic Role for the Product of sco6673-like
Based on the roles identified for the other PPTases, it appears that the sco6673-like gene could play a pleiotropic role and may be involved in multiple P-pant requiring pathways in which the other PPTases do not act. Therefore, its role could be different to the one described for its orthologue sco6673 in S. coelicolor A3(2). Its product (226 aa) shows 83% identity (87% similarity) with the SCO6673 protein of S. coelicolor A3(2) and belongs to the F/KES subfamily (Fig. S7).
Contrary to the other PPTase mutants, the deletion of sco6673-like appears to affect the morphological differentiation. Indeed, when grown on agar plates (SFM agar medium), the mutant colonies did not show the characteristic spore pigmentation (Fig. 4A) suggesting that the protein SCO6673-like is responsible for the phosphopantetheinylation of the ACP involved in the biosynthesis of the spore pigment. Complementation experiments with the pIB-sco6673-like plasmid (see Material and Methods) confirmed the involvement of SCO6673-like in the spore pigment production (Fig. 4A). It should be noted that the sco6673-like gene probably forms a single transcriptional unit with the upstream and overlapping gene which codes for a protein of unknown function but for the complementation only sco6673-like was placed downstream of ermE*p. Analysis of the colonies by scanning electron microscopy revealed that the deletion of sco6673-like does not seem to impair the ability of the mutant to sporulate (Fig. S8). Therefore, these results support the involvement of sco6673-like in the spore pigment biosynthesis.
(A) Pigmentation of the S. ambofaciens colonies grown on SFM agar plates after 6 days at 30°C. The Δsco6673-like mutant containing or not the vector is whitish while the complemented mutant strain (Δsco6673-like/pIBsco6673-like) shows a grey pigmentation similar to the WT strain; (B) Orange pigment synthesis was assessed on R2 plates in the wild-type (WT) strain and in the Δsco6673-like mutant as well as in the complemented Δsco6673-like mutant (Δsco6673-like/pIBsco6673-like) and the control strain Δsco6673-like/pIB139. The photo was taken from below the plate.
We then analyzed the biosynthesis of the secondary metabolites known to depend on clusters devoid of any PPTase gene. Bioassays and HPLC analysis of culture extracts were carried out from strains grown on MP5 and HT agar plates, since these media are known to be suitable for the production of spiramycin and congocidine. The Δsco6673-like::scar mutant did not exhibit any activity onto the congocidine sensitive E. coli compared to the wt strain. Complementation experiments (strain Δsco6673-like/pIB-sco6673-like) confirmed that the deletion of sco6673-like was responsible for the loss of the antibacterial activity (Fig. S9) and HPLC analyses of supernatant extracts from liquid cultures grown in MP5 verified that the deletion of sco6673-like in S. ambofaciens ATCC23877 prevents the production of congocidine (Fig. 5). Analogous results were obtained for the spiramycin production (Fig. 5).
(A) Spiramycin and congocidine production was assessed directly by HPLC from supernatant samples collected from the culture of S. ambofaciens ATCC23877 wild-type and mutant strains grown in liquid MP5. Commercial spiramycin (100 µl at 0.1 mg/ml) was used as control. Absorption was monitored at 232 nm. The inserts are an enlargement of the area between 20 to 35 min of retention time containing the peaks corresponding to the spiramycin (spiramycin is a mixture of three forms). The peak corresponding to congocidine is highlighted with a black dot. (B) UV spectra (from 200 to 350 nm) of the peaks highlighted with an asterisk and corresponding to spiramycin.
The production of stambomycins in the mutant strain was tested from a clone overexpressing samR0484 (strain Δsco6673-like/OE484) and grown on R2 agar medium. LC-MS analyses from methanolic mycelium extracts showed that the macrolides are not detectable in the mutant extracts while the wt strain carrying pOE-0484 (ATCC/OE484) produced large amount of stambomycins (Fig. 6; Fig. S10). These data demonstrated that the acyl-carrier domains of the stambomycin biosynthetic pathways are activated by the PPTase SCO6673-like.
(A) Stambomycin production: UV chromatograms at 215 nm from LC-MS analyses of the extracts of Δsco6673-like/OE484 (top) and ATCC/OE484 (middle) and ion chromatogram (bottom, m/z 682 and 689) corresponding to the dicharged [M+2H]2+ stambomycins C/D (m/z 682) and stambomycins A/B (m/z 689) [24]. (B) Coelichelin production: ion chromatograms from LC-MS analyses of the extracts, from top to bottom, of the S. ambofaciens wild type strain, the Δsco6673-like mutant, the Δsco6673-like/pIB139 strain and the Δsco6673-like/pIBsco6673-like strain. Peaks with a retention time of 3.2 min correspond to the desferri- form of coelichelin.
The last known compound whose production was hypothesized to be dependent of SCO6673-like is coelichelin. Recently, it has been shown that the siderophores coelichelin and desferrioxamines are produced by S. coelicolor A3(2) on R2YE solid medium [41]. From the same growth conditions, LC-MS analyses revealed the presence of coelichelin only in the wt strain but not in the Δsco6673-like::scar mutant (Fig. 6; Fig. S10). The production of this molecule was fully restored in the complemented mutant. Thus, we concluded that the PPTase SCO6673-like activates the PCP domains of the NRPS required for coelichelin biosynthesis. The LC-MS analyses also showed that the production of the desferrioxamine E and B was not impaired by the deletion of sco6673-like (data not shown), as expected, since they are members of the nonpeptide hydroxamate siderophores.
Although SCO6673-like was not expected to be involved in the kinamycin and antimycin pathways, we nevertheless analyzed the mutant strain for the production of these metabolites. Surprisingly, on R2 medium, a diffusible brown pigmentation was observed around the mutants instead of the orange pigment observed with the parental strain (Fig. 4B). This phenotype was directly linked to the deletion of sco6673-like since the reintroduction of the wt allele in the mutant restored the orange pigmentation (Fig. 4B). We hypothesize that the level of kinamycin and pigment production is higher in the mutant strain compared to the wt strain due to a larger amount of available precursors in the mutant. Unexpectedly, the production of antimycins was abolished in the Δsco6673-like mutant grown on SFM agar medium as observed by LC-MS analysis (Fig. 3). Complementation with the wt allele of sco6673-like restored the production (Fig. 3). These data revealed that the product of sco6673-like acts in concert with SAML0372 for the activation of the carrier domains involved in the biosynthesis of the antifungal compounds. However, the targets of SAML0372 and SCO6673-like have not been identified. Nevertheless, they should be different since the absence of one of the PPTase was not counterbalanced by the presence of the other. Therefore, one may speculate that one of these PPTases may activate the ACP domains while the other could act on the PCP domains encoded within the antimycin biosynthetic gene cluster.
Discussion
We have determined the role of the four PPTase genes encoded within the genome of S. ambofaciens ATCC23877. The only PPTase of the ACPS-type family, SCO4744-like, is likely responsible for the activation of the carrier protein involved in the fatty acid biosynthesis since its gene appears to be essential, as its orthologue in S. coelicolor A3(2) [5]. Therefore, although the bacteria of the Streptomyces genus encode several Sfp-type genes, their products cannot complement the activity of ACPSs, a situation different than the one observed for the promiscuous Sfp of B. subtilis [45]. In addition, the role of the Streptomyces ACPS seems to vary from one species to another. Thus, in S. ambofaciens, the role of this transferase is more restricted than in S. coelicolor in which SCO4744 was reported to be also competent in vivo for the modification of ACPs involved in the actinorhodin, undecylprodigiosin and spore pigment production [5]. Recently, it has been reported that the ACPS-like enzyme of Streptomyces chattanoogensis L10 was also required for the spore pigment production in addition to its involvement in the fatty acid production [46]. This suggests that the function of two related genes/proteins has evolved differently in the two closely related Streptomyces species. A similar situation has been encountered with the Sfp-type PPTases, SCO6673-like of S. ambofaciens and SCO6673 of S. coelicolor. While in S. coelicolor the latter PPTase has been proposed to activate specifically PCPs [5], as usually described for the PPTases of the F/KES family, its role appears to be promiscuous in S. ambofaciens: it not only modifies PCPs (e.g. the one involved in the siderophore coelichelin production), but also ACPs (e.g. the ACP involved in the spore pigment biosynthesis or the carrier domains of the type I PKSs responsible for the spiramycin production). SCO6673-like is nevertheless not active on all ACPs, since AlpC, encoded by the type II PKS alp cluster (kinamycin) is transformed into its holo form by the Sfp-type AlpN, a member of the W/KEA family. At this stage, it is difficult to explain the difference of specificity between SCO6673 and SCO6673-like. The proteins are highly conserved (83%/87% of identity/similarity at the aa level) and the residues essential for the activity and structural stability within the conserved motifs (Fig. S7) are shared by the two enzymes. In addition, they show the same genetic organisation, i.e. like in S. coelicolor A3(2) (and the majority of the other Streptomyces sequenced genomes) the PPTase gene is located downstream of and overlapping a conserved gene of unknown function with a calcineurin-like phosphoesterase domain (Pfam00149). Some residues that are different between the two PPTases (e.g. those located within the conserved motifs) might explain the specificity of each of the enzymes, or additional factors might influence the specificity of the PPTases (such as the product of the upstream gene). It will be interesting to test if the SCO6673 protein of S. coelicolor A3(2) can substitute its orthologue in S. ambofaciens. To the best of our knowledge, it is the first time that, in Streptomyces, a Sfp-type protein is demonstrated in vivo to possess such a relaxed specificity towards a wide range of partners including both peptidyl- and acyl-carrier proteins/domains. Only the ACPs involved in kinamycin and fatty acid biosynthesis and probably some of the carrier proteins or domains (PCP or ACP) involved in antimycin production show no activation by SCO6673-like (see below). In addition, SCO6673-like could be involved in the activation of the ACP and PCP domains encoded by the still cryptic type I PKS and NRPS gene clusters identified in the S. ambofaciens ATCC23877 chromosome by genome mining. Other members of the F/KES family in Streptomyces are also flexible in terms of carrier proteins such as KirP of Streptomyces collinus Tü365 which targets ACP and PCP domains of the kirromycin NRPS/PKS [47], but none of them have been reported to activate the two types of carrier proteins from different secondary metabolite biosynthetic pathways in vivo.
As expected, the products of the genes located within secondary metabolite gene clusters are specifically dedicated to the production of their related compounds. Thus, our data show that AlpN is involved only in the production of the kinamycin antibiotics and of its related orange pigment. SAML0372 is necessary in the biosynthesis of the antifungal antimycins and of the blastmycinones and butenolides. As described above, SAML0372 appears to be a very unusual PPTase with a long spacer located between the motif 3 and the “classical” C-terminal part of the Sfp-type PPTases of Streptomyces. No PPTase with such a characteristic structure could be detected in protein databases. Only another strain of S. ambofaciens, the strain DSM40697 encodes an orthologue of samL0372 also within an antimycin biosynthetic gene cluster (data not shown). In addition, no gene encoding a PPTase is present in the antimycin gene clusters of S. albus J1074 and Streptomyces S4 [43]. Similarly, samL0373, the gene immediately downstream samL0372, is also absent in these clusters but present in the S. ambofaciens DSM40697 strain. This suggests that the ancestor of the S. ambofaciens strains could have acquired this locus of two genes by a horizontal gene transfer event. The PPTase SAML0372 may have evolved to activate either the acyl or peptidyl carrier protein/domains involved in the biosynthesis of antimycins (and consequently of the blastmycinones and butenolides derived from antimycins) and it would have partly got the upper hand on the initial PPTase (SCO6673-like?) initially responsible for these activations. Indeed, we have demonstrated that SCO6673-like PPTase is also essential for the production of antimycins, suggesting that the two PPTases participate in the activation of the different carrier proteins encoded within the antimycin cluster. One could be responsible for the activation of PCP while the other could be responsible for the activation of ACP or they could act as heteromeric complex on both carrier proteins. Alternatively, samL0372 (and samL0373) could have been lost in the clusters of S. albus J1074 and Streptomyces S4. Indeed, analysis of the region encompassing the gene encoding the most similar protein of SAML0372, SHJG_1263 from Streptomyces hygroscopicus jinggansis 5008 (Fig. 2), revealed that this gene is located within a cluster likely responsible for the production of antimycins (Accession number NC_017765, Fig. S11). A similar situation is observed in the proposed antimycin cluster of Streptomyces blastmyceticus (Accession number AB727666, Fig. 2; Fig. S11). Nevetherless, no orthologue of samL0373 is present in these clusters suggesting that several rearrangements might have occurred at this locus. It will be interesting to test if SAML0373 is also involved in the antimycin production although it is hard to speculate about the role of this protein which contains an MT0933 antitox-like domain (Pfam14013).
Supporting Information
Figure S1.
Sequence alignment of the SCO4744-like protein (ACPS) of S. ambofaciens ATCC23877 with Streptomyces ACPS-type proteins. The aa residues conserved in at least 80% of the proteins are shaded in black.
https://doi.org/10.1371/journal.pone.0087607.s001
(PDF)
Figure S2.
Sequence alignment of SAMT0172 (AlpN) of S. ambofaciens ATCC23877 with the most similar Sfp-type PPTases from actinomycetes. The aa residues conserved in at least 8/9 proteins are black shaded. SAMT0172 belongs to the W/KEA subfamily and the motifs characteristic of this subfamily [9] are red boxed.
https://doi.org/10.1371/journal.pone.0087607.s002
(PDF)
Figure S3.
Analysis of the spiramycin production in the ΔΔalpN mutant strain. Spiramycin production was analyzed by HPLC directly from a supernatant sample collected from a culture of the ΔΔalpN mutant in MP5 liquid medium. A linear gradient from 5% to 75% acetonitrile was applied in the presence of 0.1% of trifluoroacetic acid for 70 min with a flow rate of 0.25 ml/min at a temperature of 30°C. Absorption was monitored at 232 nm. The insert shows the characteristic UV spectrum (from 200 to 350 nm) of spiramycin. The peak corresponding to the UV spectrum is labeled with an asterisk. Several peaks correspond to spiramycin (spiramycin is a mixture of three forms).
https://doi.org/10.1371/journal.pone.0087607.s003
(PDF)
Figure S4.
Analysis of the stambomycin production in the ΔΔalpN mutant strain by LC-MS. Stambomycin production was analyzed from methanolic mycelium extracts of a culture of the ΔΔalpN/OE484 (in purple) and ΔΔalpN/pIB139 (in green) strains grown in MP5 liquid medium. On the bottom of the figure, the MS chromatogram shows the characteristic mass of the doubly charged peaks (673 and 680) and of the mono charged peaks (1363 and 1377).
https://doi.org/10.1371/journal.pone.0087607.s004
(PDF)
Figure S5.
Analysis of blastmycinone and butenolide production in S. ambofaciens ATCC23877 and in the ΔΔalpN and ΔsamL0372 mutant strains by GC-MS. Total ion chromatograms of head space extracts from S. ambofaciens ATCC23877 (A), from the ΔΔalpN mutant (B) and from the ΔsamL0372 mutant (C) grown on SFM agar plates. The structures of the butenolides (1–11) and blastmycinones (A–K) detected in the extracts are shown.
https://doi.org/10.1371/journal.pone.0087607.s005
(PDF)
Figure S6.
Analysis of the production of antibiotics in the S. ambofaciens strain deleted for samL0372. (A) Orange pigment and (B) kinamycin production were assessed on R2 plates in the WT and ΔsamL0372 strains. For the pigment, the photo was taken from below the plate. Inhibition of B. subtilis growth was visualized by the dark halo surrounding the agar plug. (C) HPLC analysis of the production of spiramycin and congocidine. Production was analyzed directly from a supernatant sample (100 µl) collected from a culture of the WT and ΔsamL0372::apra-oriT strains in MP5. A linear gradient from 5% to 75% acetonitrile was applied in the presence of 0.1% of trifluoroacetic acid for 70 min with a flow rate of 0.25 ml/min at a temperature of 30°C. Commercial spiramycin and congocidine (100 µl at 0.1 mg/ml) were used as control. Absorption was monitored at 232 nm (spiramycin and congocidine) and 297 nm (congocidine). The inserts show UV spectra (from 200 to 350 nm) of the spiramycin and the congocidine. The peaks corresponding to the UV spectra are labeled with asterisks or black dots. Several peaks correspond to spiramycin (spiramycin is a mixture of three forms).
https://doi.org/10.1371/journal.pone.0087607.s006
(PDF)
Figure S7.
Sequence alignment of SCO6673-like of S. ambofaciens ATCC23877 with Sfp-type PPTases from Streptomycetes. The prototype Sfp proteins, Sfp from B. subtilis and EntD from E. coli, are included in the alignment. The aa residues conserved in at least 10/12 proteins are shaded in black. SCO6673-like belongs to the F/KES subfamily. The motifs characteristic of this subfamily are red boxed and the asterisks indicate residues implicated in stability or activity roles [9].
https://doi.org/10.1371/journal.pone.0087607.s007
(RTF)
Figure S8.
Scanning electron micrograph of the surfaces of the S. ambofaciens ATCC23877 wild-type and Δsco6673-like colonies. All strains were grown at 30°C for 6 days on SFM agar plates. To prepare specimens, agar plugs were fixed with 2% osmium tetroxide for 40 h and then dehydrated by air-drying. Each specimen was sputter-coated on platinum/gold and examined with a CAMBRIDGE Stereoscan S240 scanning electron microscope. Bars: 10 µm.
https://doi.org/10.1371/journal.pone.0087607.s008
(PDF)
Figure S9.
Effect of the deletion of sco6673-like on the congocidine production. Congocidine bioassay was carried out on HT agar plates. After 5 days of growth at 30°C of the Streptomyces sco6673-like mutants, the plate was overlaid with soft nutrient agar containing E. coli as indicator strain. The production of congocidine was visualized by the inhibition of the indicator microorganism growth. Inhibition is only detectable for the complemented mutant strain (Δsco6673-like/pIBsco6673-like).
https://doi.org/10.1371/journal.pone.0087607.s009
(PDF)
Figure S10.
MS spectra of the stambomycins and MS and MS2 spectra of coelichelin from S. ambofaciens ATCC23877. (A) MS spectra of stambomycins C/D (top) and stambomycins A/B (bottom) corresponding to the peaks of interest on the ion chromatogram for the ATCC/OE484 strain (see Fig. 6). The [M+2H-H2O]2+, [M+2H]2+ and [M+H]+ forms of stambomycins C/D (m/z 673, 682 and 1363, respectively) and stambomycins A/B (m/z 680, 689 and 1377, respectively) are indicated. (B) MS and MS2 spectra of [M+H]+ ion of coelichelin (desferri- form) from the WT extract (see Fig. 6). The spectra are consistent with published MS and MS2 spectra [53].
https://doi.org/10.1371/journal.pone.0087607.s010
(PDF)
Figure S11.
Alignment of antimycin biosynthetic gene clusters. The first characterized antimycin biosynthetic gene cluster, the one of the symbiont Streptomyces S4 [43] is used as reference for the annotation. The PPTase encoding genes, which are present in the cluster of S. ambofaciens ATCC23877 (AM238663), S. hygroscopicus subsp. jinggangensis 5008 (NC_017765) and S. blastmyceticus (AB727666) but absent in the cluster of Streptomyces S4, are labeled with a white asterisk within the ORF. The black asterisk indicates the samL0373 gene which appears to be specific of S. ambofaciens. The potential targets of the SAML0372 PPTase (but also of SCO6673-like) are the ACP and PCP domains encoded by the PKS and NRPS genes, respectively and the product (PCP) of the antG orthologue which is conserved within all the antimycin biosynthetic gene clusters. The comparison of the clusters was done by antiSMASH [54] using the cluster of S. hygroscopicus subsp. jinggangensis 5008 as a query.
https://doi.org/10.1371/journal.pone.0087607.s011
(PDF)
Table S1.
Oligonucleotide primers used in this work.
https://doi.org/10.1371/journal.pone.0087607.s012
(PDF)
Acknowledgments
We thank Jérôme Chevrier and Bernard Foliguet (Université de Lorraine, France) for the SEM analyses and Peter Leadlay (University of Cambridge, United Kingdom) for the kind gift of pIB139.
Author Contributions
Conceived and designed the experiments: BA JSD. Performed the experiments: RB RR LL LH BA CP JMG. Analyzed the data: BA PL DS JSD RB RR CP. Contributed reagents/materials/analysis tools: JMG CP. Wrote the paper: BA. Read and approve the final manuscript: RB JSD DS PL.
References
- 1. Walsh CT, Gehring AM, Weinreb PH, Quadri LE Flugel RS (1997) Post-translational modification of polyketide and nonribosomal peptide synthases. Curr Opin Chem Biol 1: 309–315.
- 2. Lambalot RH, Gehring AM, Flugel RS, Zuber P, LaCelle M, et al. (1996) A new enzyme superfamily - the phosphopantetheinyl transferases. Chem Biol 3: 923–936.
- 3. Lambalot RH, Walsh CT (1995) Cloning, overproduction, and characterization of the Escherichia coli holo-acyl carrier protein synthase. J Biol Chem 270: 24658–24661.
- 4. Gehring AM, Lambalot RH, Vogel KW, Drueckhammer DG, Walsh CT (1997) Ability of Streptomyces spp. acyl carrier proteins and coenzyme A analogs to serve as substrates in vitro for E. coli holo-ACP synthase. Chem Biol 4: 17–24.
- 5. Lu YW, San Roman AK, Gehring AM (2008) Role of phosphopantetheinyl transferase genes in antibiotic production by Streptomyces coelicolor. J Bacteriol 190: 6903–6908.
- 6. Quadri LE, Weinreb PH, Lei M, Nakano MM, Zuber P, et al. (1998) Characterization of Sfp, a Bacillus subtilis phosphopantetheinyl transferase for peptidyl carrier protein domains in peptide synthetases. Biochemistry 37: 1585–1595.
- 7. Mofid MR, Finking R, Essen LO, Marahiel MA (2004) Structure-based mutational analysis of the 4′-phosphopantetheinyl transferases Sfp from Bacillus subtilis: carrier protein recognition and reaction mechanism. Biochemistry 43: 4128–4136.
- 8. Roberts AA, Copp JN, Marahiel MA, Neilan BA (2009) The Synechocystis sp. PCC6803 Sfp-type phosphopantetheinyl transferase does not possess characteristic broad-range activity. Chembiochem 10: 1869–1877.
- 9. Copp JN, Neilan BA (2006) The phosphopantetheinyl transferase superfamily: phylogenetic analysis and functional implications in cyanobacteria. Appl Environ Microbiol 72: 2298–2305.
- 10. Asghar AH, Shastri S, Dave E, Wowk I, Agnoli K, et al. (2011) The pobA gene of Burkholderia cenocepacia encodes a group I Sfp-type phosphopantetheinyltransferase required for biosynthesis of the siderophores ornibactin and pyochelin. Microbiology 157: 349–361.
- 11. Nakano MM, Marahiel MA, Zuber P (1988) Identification of a genetic locus required for biosynthesis of the lipopeptide antibiotic surfactin in Bacillus subtilis. J Bacteriol 170: 5662–5668.
- 12. Silakowski B, Schairer HU, Ehret H, Kunze B, Weinig S, et al. (1999) New lessons for combinatorial biosynthesis from myxobacteria. The myxothiazol biosynthetic gene cluster of Stigmatella aurantiaca DW4/3–1. J Biol Chem 274: 37391–37399.
- 13. Sanchez C, Du L, Edwards DJ, Toney MD, Shen B (2001) Cloning and characterization of a phosphopantetheinyl transferase from Streptomyces verticillus ATCC15003, the producer of the hybrid peptide-polyketide antitumor drug bleomycin. Chem Biol 8: 725–738.
- 14. Fichtlscherer F, Wellein C, Mittag M, Schweizer E (2000) A novel function of yeast fatty acid synthase. Subunit alpha is capable of self-pantetheinylation. Eur J Biochem 267: 2666–2671.
- 15. Bentley SD, Chater KF, Cerdeno-Tarraga AM, Challis GL, Thomson NR, et al. (2002) Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature 417: 141–147.
- 16. Cerdeno AM, Bibb MJ, Challis GL (2001) Analysis of the prodiginine biosynthesis gene cluster of Streptomyces coelicolor A3(2): new mechanisms for chain initiation and termination in modular multienzymes. Chem Biol 8: 817–829.
- 17. Ohnishi Y, Ishikawa J, Hara H, Suzuki H, Ikenoya M, et al. (2008) Genome sequence of the streptomycin-producing microorganism Streptomyces griseus IFO 13350. J Bacteriol 190: 4050–4060.
- 18. Omura S, Ikeda H, Ishikawa J, Hanamoto A, Takahashi C, et al. (2001) Genome sequence of an industrial microorganism Streptomyces avermitilis: deducing the ability of producing secondary metabolites. Proc Natl Acad Sci U S A 98: 12215–12220.
- 19. Ikeda H, Ishikawa J, Hanamoto A, Shinose M, Kikuchi H, et al. (2003) Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis. Nat Biotechnol 21: 526–531.
- 20.
Stanley AE, Walton LJ, Kourdi Zerikly M, Corre C, Challis GL (2006) Elucidation of the Streptomyces coelicolor pathway to 4-methoxy-2,2′-bipyrrole-5-carboxaldehyde, an intermediate in prodiginine biosynthesis. Chem Commun (Camb): 3981–3983.
- 21.
Aigle B, Lautru S, Spiteller D, Dickschat JS, Challis GL, et al.. (2013) Genome mining of Streptomyces ambofaciens. J Ind Microbiol Biotechnol [Epub ahead of print].
- 22. Karray F, Darbon E, Oestreicher N, Dominguez H, Tuphile K, et al. (2007) Organization of the biosynthetic gene cluster for the macrolide antibiotic spiramycin in Streptomyces ambofaciens. Microbiology 153: 4111–4122.
- 23. Juguet M, Lautru S, Francou FX, Nezbedova S, Leblond P, et al. (2009) An iterative nonribosomal peptide synthetase assembles the pyrrole-amide antibiotic congocidine in Streptomyces ambofaciens. Chem Biol 16: 421–431.
- 24. Laureti L, Song L, Huang S, Corre C, Leblond P, et al. (2011) Identification of a bioactive 51-membered macrolide complex by activation of a silent polyketide synthase in Streptomyces ambofaciens. Proc Natl Acad Sci U S A 108: 6258–6263.
- 25. Pang X, Aigle B, Girardet JM, Mangenot S, Pernodet JL, et al. (2004) Functional angucycline-like antibiotic gene cluster in the terminal inverted repeats of the Streptomyces ambofaciens linear chromosome. Antimicrob Agents Chemother 48: 575–588.
- 26. Bunet R, Song L, Mendes MV, Corre C, Hotel L, et al. (2011) Characterization and manipulation of the pathway-specific late regulator AlpW reveals Streptomyces ambofaciens as a new producer of Kinamycins. J Bacteriol 193: 1142–1153.
- 27. Barona-Gomez F, Lautru S, Francou FX, Leblond P, Pernodet JL, et al. (2006) Multiple biosynthetic and uptake systems mediate siderophore-dependent iron acquisition in Streptomyces coelicolor A3(2) and Streptomyces ambofaciens ATCC 23877. Microbiology 152: 3355–3366.
- 28. Schoenian I, Paetz C, Dickschat JS, Aigle B, Leblond P, et al. (2012) An unprecedented 1,2-shift in the biosynthesis of the 3-aminosalicylate moiety of antimycins. Chembiochem 13: 769–773.
- 29. Riclea R, Aigle B, Leblond P, Schoenian I, Spiteller D, et al. (2012) Volatile lactones from streptomycetes arise via the antimycin biosynthetic pathway. Chembiochem 13: 1635–1644.
- 30. Choulet F, Aigle B, Gallois A, Mangenot S, Gerbaud C, et al. (2006) Evolution of the terminal regions of the Streptomyces linear chromosome. Mol Biol Evol 23: 2361–2369.
- 31.
Kieser T, Bibb MJ, Buttner MJ, Chater KF, Hopwood DA (2000) Practical Streptomyces Genetics. John Innes.
- 32. Pernodet JL, Alegre MT, Blondelet-Rouault MH, Guerineau M (1993) Resistance to spiramycin in Streptomyces ambofaciens, the producer organism, involves at least two different mechanisms. J Gen Microbiol 139: 1003–1011.
- 33.
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, New-York: Cold Spring Harbor Laboratory Press.
- 34. Leblond P, Francou FX, Simonet JM, Decaris B (1990) Pulsed-field gel electrophoresis analysis of the genome of Streptomyces ambofaciens strains. FEMS Microbiol Lett 60: 79–88.
- 35. Gust B, Challis GL, Fowler K, Kieser T, Chater KF (2003) PCR-targeted Streptomyces gene replacement identifies a protein domain needed for biosynthesis of the sesquiterpene soil odor geosmin. Proc Natl Acad Sci U S A 100: 1541–1546.
- 36. Bunet R, Mendes MV, Rouhier N, Pang X, Hotel L, et al. (2008) Regulation of the synthesis of the angucyclinone antibiotic alpomycin in Streptomyces ambofaciens by the autoregulator receptor AlpZ and its specific ligand. J Bacteriol 190: 3293–3305.
- 37. Raynal A, Karray F, Tuphile K, Darbon-Rongere E, Pernodet JL (2006) Excisable cassettes: new tools for functional analysis of Streptomyces genomes. Appl Environ Microbiol 72: 4839–4844.
- 38. Datsenko KA, Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97: 6640–6645.
- 39. Aigle B, Pang X, Decaris B, Leblond P (2005) Involvement of AlpV, a new member of the Streptomyces antibiotic regulatory protein family, in regulation of the duplicated type II polyketide synthase alp gene cluster in Streptomyces ambofaciens. J Bacteriol 187: 2491–2500.
- 40. Dickschat JS, Wenzel SC, Bode HB, Muller R, Schulz S (2004) Biosynthesis of volatiles by the myxobacterium Myxococcus xanthus. Chembiochem 5: 778–787.
- 41. Craig M, Lambert S, Jourdan S, Tenconi E, Colson S, et al. (2012) Unsuspected control of siderophore production by N-acetylglucosamine in streptomycetes. Environ Microbiol Rep 4: 512–521.
- 42. Mochizuki S, Hiratsu K, Suwa M, Ishii T, Sugino F, et al. (2003) The large linear plasmid pSLA2-L of Streptomyces rochei has an unusually condensed gene organization for secondary metabolism. Mol Microbiol 48: 1501–1510.
- 43. Seipke RF, Barke J, Brearley C, Hill L, Yu DW, et al. (2011) A single Streptomyces symbiont makes multiple antifungals to support the fungus farming ant Acromyrmex octospinosus. PLoS One 6: e22028.
- 44. Sandy M, Rui Z, Gallagher J, Zhang W (2012) Enzymatic synthesis of dilactone scaffold of antimycins. ACS Chem Biol 7: 1956–1961.
- 45. Mootz HD, Finking R, Marahiel MA (2001) 4′-phosphopantetheine transfer in primary and secondary metabolism of Bacillus subtilis. J Biol Chem 276: 37289–37298.
- 46. Jiang H, Wang YY, Ran XX, Fan WM, Jiang XH, et al. (2013) Improvement of natamycin production by engineering of phosphopantetheinyl transferases in Streptomyces chattanoogensis L10. Appl Environ Microbiol 79: 3346–3354.
- 47. Pavlidou M, Pross EK, Musiol EM, Kulik A, Wohlleben W, et al. (2011) The phosphopantetheinyl transferase KirP activates the ACP and PCP domains of the kirromycin NRPS/PKS of Streptomyces collinus Tü 365. FEMS Microbiol Lett 319: 26–33.
- 48. Pinnert-Sindico S (1954) Une nouvelle espèce de Streptomyces productrice d’antibiotiques : Streptomyces ambofaciens n. sp. caractères culturaux. Ann Inst Pasteur (Paris) 87: 702–707.
- 49. Hanahan D (1983) Studies on transformation of Escherichia coli with plasmids. J Mol Biol 166: 557–580.
- 50. MacNeil DJ, Gewain KM, Ruby CL, Dezeny G, Gibbons PH, et al. (1992) Analysis of Streptomyces avermitilis genes required for avermectin biosynthesis utilizing a novel integration vector. Gene 111: 61–68.
- 51. Wilkinson CJ, Hughes-Thomas ZA, Martin CJ, Bohm I, Mironenko T, et al. (2002) Increasing the efficiency of heterologous promoters in actinomycetes. J Mol Microbiol Biotechnol 4: 417–426.
- 52. Bierman M, Logan R, O’Brien K, Seno ET, Rao RN, et al. (1992) Plasmid cloning vectors for the conjugal transfer of DNA from Escherichia coli to Streptomyces spp. Gene 116: 43–49.
- 53. Lautru S, Deeth RJ, Bailey LM, Challis GL (2005) Discovery of a new peptide natural product by Streptomyces coelicolor genome mining. Nat Chem Biol 1: 265–269.
- 54. Medema MH, Blin K, Cimermancic P, de Jager V, Zakrzewski P, et al. (2011) antiSMASH: rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences. Nucleic Acids Res 39: W339–346.